| 臺大學術典藏 |
2022-08-19T00:20:55Z |
Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy
|
Shau W.-Y.; Chen T.-J.; Yang S.-H.; Huang S.-M.; CHIUN HSU; Lu Y.-S.; Cheng A.-L.; Lin C.-H.; Kuo Y.-H. |
| 臺大學術典藏 |
2022-08-12T06:28:15Z |
Differential expression of glucocorticoid receptor in human breast tissues and related neoplasms
|
Lien H.-C.; Lu Y.-S.; Cheng A.-L.; Chang W.-C.; Jeng Y.-M.; Kuo Y.-H.; Huang C.-S.; KING-JEN CHANG; Yao Y.-T. |
| 臺大學術典藏 |
2022-08-12T06:28:14Z |
Expression of PEA3 and lack of correlation between PEA3 and HER-2/neu expression in breast cancer
|
Xia W.-Y.; Lien H.-C.; Wang S.-C.; Pan Y.; Sahin A.; Kuo Y.-H.; KING-JEN CHANG; Zhou X.; Wang H.; Yu Z.; Hortobagyi G.; Shi D.-R.; Hung M.-C. |
| 臺大學術典藏 |
2022-08-12T06:27:53Z |
Effects of monascus-fermented rice extract on malignant cell-associated neovascularization and intravasation determined using the chicken embryo chorioallantoic membrane model
|
Ho B.-Y.; Wu Y.-M.; Hsu Y.-W.; Hsu L.-C.; Kuo Y.-H.; KING-JEN CHANG; Pan T.-M. |
| 臺大學術典藏 |
2022-06-10T06:11:09Z |
Survival of patients with small cell lung carcinoma in Taiwan
|
Kuo Y.-H.; ZHONG-ZHE LIN; Yang Y.-Y.; Shao Y.-Y.; Shau W.-Y.; Kuo R.N.C.; Yang J.C.-H.; Lai M.-S. |
| 臺大學術典藏 |
2022-04-25T06:13:11Z |
Bracteanolide A abrogates oxidative stress-induced cellular damage and protects against hepatic ischemia and reperfusion injury in rats
|
Chao T.-Y;Hsieh C.-C;Kuo Y.-H;Yu Y.-J;Wan C.-H;Hsieh S.-C.; Chao T.-Y; Hsieh C.-C; Kuo Y.-H; Yu Y.-J; Wan C.-H; Hsieh S.-C.; SHU-CHEN HSIEH |
| 臺大學術典藏 |
2022-04-25T03:57:55Z |
Bracteanolide A abrogates oxidative stress-induced cellular damage and protects against hepatic ischemia and reperfusion injury in rats
|
Chao T.-Y;Hsieh C.-C;Kuo Y.-H;Yu Y.-J;Wan C.-H;Hsieh S.-C.; Chao T.-Y; Hsieh C.-C; Kuo Y.-H; Yu Y.-J; Wan C.-H; Hsieh S.-C.; CHO-HUA WAN |
| 臺大學術典藏 |
2022-03-08T03:44:07Z |
Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials
|
SHIH-HUNG YANG; Kuo Y.-H.; Tien Y.-W.; Hsu C.; Hsu C.-H.; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-03-08T03:44:06Z |
Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy
|
Kuo Y.-H.; Lin C.-H.; Shau W.-Y.; Chen T.-J.; SHIH-HUNG YANG; Huang S.-M.; Hsu C.; Lu Y.-S.; Cheng A.-L. |
| 臺大學術典藏 |
2022-02-23T02:12:21Z |
Liver stiffness-based score at sustained virologic response predicts liver-related complications after eradication of hepatitis C virus
|
Kuo Y.-H.; Kee K.-M.; Hung C.-H.; Lu S.-N.; Hu T.-H.; CHIEN-HUNG CHEN; Wang J.-H. |
| 臺大學術典藏 |
2022-02-23T02:12:18Z |
Corrigendum: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis (Front. Oncol., (2021), 11, (737767), 10.3389/fonc.2021.737767)
|
Kuo Y.-H.; Lu S.-N.; Chen Y.-Y.; Kee K.-M.; Yen Y.-H.; Hung C.-H.; Hu T.-H.; CHIEN-HUNG CHEN; Wang J.-H. |
| 臺大學術典藏 |
2022-02-23T02:12:18Z |
Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
|
Kuo Y.-H.; Lu S.-N.; Chen Y.-Y.; Kee K.-M.; Yen Y.-H.; Hung C.-H.; Hu T.-H.; CHIEN-HUNG CHEN; Wang J.-H. |
| 臺大學術典藏 |
2022-02-22T05:34:11Z |
Liver stiffness-based score at sustained virologic response predicts liver-related complications after eradication of hepatitis C virus
|
Kuo Y.-H.; Kee K.-M.; Hung C.-H.; Lu S.-N.; Hu T.-H.; CHIEN-HUNG CHEN; Wang J.-H. |
| 臺大學術典藏 |
2022-02-22T05:34:08Z |
Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
|
Kuo Y.-H.; Lu S.-N.; Chen Y.-Y.; Kee K.-M.; Yen Y.-H.; Hung C.-H.; Hu T.-H.; CHIEN-HUNG CHEN; Wang J.-H. |
| 臺大學術典藏 |
2022-02-22T05:34:07Z |
Corrigendum: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis (Front. Oncol., (2021), 11, (737767), 10.3389/fonc.2021.737767)
|
Kuo Y.-H.; Lu S.-N.; Chen Y.-Y.; Kee K.-M.; Yen Y.-H.; Hung C.-H.; Hu T.-H.; CHIEN-HUNG CHEN; Wang J.-H. |
| 國立成功大學 |
2022 |
A synthesized retail brand personality framework: a�cross-cultural study of Taiwan and the United States
|
Kuo, Y.-H.;Wu, P.-C.;Ahn, S.Y. |
| 國立成功大學 |
2022 |
Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated Cardiovascular Toxicities
|
Wu, N.-C.;Feng, Y.-H.;Kuo, Y.H.;Chen, W.-Y.;Wu, H.-C.;Huang, C.-T.;Wang, Wang W.-C.;Kang, N.-W.;Shih, J.-Y.;Chen, Z.-C.;Chang, W.-T. |
| 國立成功大學 |
2022 |
The retail brand personality—Behavioral outcomes framework: Applications to identity and social identity theories
|
Kuo, Y.-H. |
| 臺大學術典藏 |
2021-10-04T07:15:51Z |
Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin result in synergistic cytotoxic effect in combination with capecitabine
|
JEN-CHANG KO; Tsai M.-S.; Kuo Y.-H.; Chiu Y.-F.; Weng S.-H.; Su Y.-C.; Lin Y.-W. |
| 臺大學術典藏 |
2021-10-04T07:15:51Z |
Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2
|
JEN-CHANG KO; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Chiu Y.-F.; Kuo Y.-H.; Tsai M.-S.; Lin Y.-W. |
| 臺大學術典藏 |
2021-10-04T07:15:50Z |
Up-regulation of extracellular signal-regulated kinase 1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small-cell lung cancer cells
|
JEN-CHANG KO; Tsai M.-S.; Chiu Y.-F.; Weng S.-H.; Kuo Y.-H.; Lin Y.-W. |
| 臺大學術典藏 |
2021-10-04T07:15:50Z |
Curcumin enhances the mitomycin C-induced cytotoxicity via downregulation of MKK1/2-ERK1/2-mediated Rad51 expression in non-small cell lung cancer cells
|
JEN-CHANG KO; Tsai M.-S.; Weng S.-H.; Kuo Y.-H.; Chiu Y.-F.; Lin Y.-W. |
| 臺大學術典藏 |
2021-09-01T02:02:10Z |
Differential expression of glucocorticoid receptor in human breast tissues and related neoplasms
|
Lien H.-C.; Lu Y.-S.; ANN-LII CHENG; Chang W.-C.; Jeng Y.-M.; Kuo Y.-H.; Huang C.-S.; Chang K.-J.; Yao Y.-T. |
| 臺大學術典藏 |
2021-09-01T01:54:05Z |
Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials
|
Yang S.-H.; Kuo Y.-H.; Tien Y.-W.; Hsu C.; Hsu C.-H.; Kuo S.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:53:55Z |
Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy
|
Kuo Y.-H.; Lin C.-H.; Shau W.-Y.; Chen T.-J.; Yang S.-H.; Huang S.-M.; Hsu C.; Lu Y.-S.; ANN-LII CHENG |
